Calendar
Groups
Print Newsletters
Donate to PRO!July 1, 2023
ICBII Update on the Road to the Cure - July 2023
A Real-Time Science Report This is a reprint of a previous report. Dr. Bhatt will be back next month with a fresh update. This article focuses...
Read More
June 1, 2023
ICBII Update on the Road to the Cure - June 2023
A Real-Time Science Report I came across an interesting article about possible causes for Parkinson’s that the Parkinson’s community may like to know. Dr. Ray...
April 1, 2023
ICBII Update on the Road to the Cure - April 2023
Parkinson’s disease is the most common neurodegenerative movement disorder characterized by bradykinesia, rigidity, postural instability, and tremor at rest. Dopamine replacement therapy is the...
March 1, 2023
ICBII Update on the Road to the Cure - March 2023
A Real-Time Science ReportRam S. Bhatt, PhD., Chief Science Officer RISKS OF STEM CELL TRANSPLANT THERAPY FOR PARKINSON'S DISEASE On February 9, 2023, Magenta Therapeutics reported...
January 1, 2023
ICBII UPDATE ON THE ROAD TO THE CURE - JANUARY 2023
A New Potential Therapeutic Target for Parkinson’s Disease Neurodegenerative Parkinson’s disease is characterized by a progressive loss of dopaminergic neurons from the nigrostriatal pathway, formation...
December 1, 2022
ICBII Update on the Road to the Cure - December 2022
A Real-Time Science ReportRam S. Bhatt, PhD., Chief Science Officer EFFORTS TOWARDS A PARKINSON’S CURE The cure of any disease, including Parkinson’s, depends upon two key...
June 30, 2022
ICBII Update on the Road to the Cure - July 2022
A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer The Role of LRRK2 in Parkinson’s disease – Mutations in the leucine-rich repeat kinase 2...
April 28, 2022
President's Message (May 2022)
MAY you always be the happiest person you can be through the breezes and tides; May carries with it a second chance. The month...
April 28, 2022
ICBII UPDATE ON THE ROAD TO THE CURE (May 2022)
Solving the Blood-Brain Barrier Conundrum in CNS Drug Development Last month’s editorial remarks by Jo Rosen being reprinted: in 1998 I was told by Robert...
January 31, 2022
Message from the President (February 2022)
Welcome to the “little month,” where, this year, the Chinese Lunar New Year celebrates the Water Tiger, the king of all beasts. “Our Hearts Beat...
December 29, 2021
Update on the Road to the Cure - January 2022
A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer ICBII is named among big pharma developing technology to cross the BBB Parkinson’s Cure May Be Closer...
October 1, 2021
UPDATE ON THE ROAD TO THE CURE - OCTOBER 2021
ICBII UPDATE ON THE ROAD TO THE CURE Ram S. Bhatt, PhD., Chief Science Officer LA JOLLA, CA / Sept. 22, 2021/PRNewswire/ Innovative California Biosciences International, Inc., (“ICBII”), has...
May 1, 2021
Should this be the Case, Estrogen Therapy should improve Cognition and Motor Function of...
UPDATE ON THE ROAD TO THE CURE Ram S. Bhatt, PhD., Chief Science Officer Is there a Gender Difference in the Integrity of the Blood-Brain Barrier...
April 1, 2021
UNFORTUNATELY, ONLY A SMALL FRACTION OF L-DOPA EVER REACHES THE BRAIN
UPDATE ON THE ROAD TO THE CURE A REAL-TIME SCIENCE REPORT Unfortunately, only a small fraction of L-dopa ever reaches the brain... Parkinson’s disease (PD) is a...
March 1, 2021
CONTINUATION OF THE ROLE OF NEURO-INFLAMMATION IN PARKINSON’S DISEASE
UPDATE ON THE ROAD TO THE CURE A REAL-TIME SCIENCE REPORT CONTINUATION OF THE ROLE OF NEURO-INFLAMMATION IN PARKINSON’S DISEASE “ICBII” has developed a novel class of...
